Tag: ds/pv

  • Language and Translations in PV

    Language and Translations in PV

    Pharmacovigilance expert Bart Cobert examines the issues associated with language translation in PV and drug safety.

  • Data Monitoring Committees: Observations & Issues – Part I

    Data Monitoring Committees: Observations & Issues – Part I

    Data Safety Management Boards (DSMBs), also known as Data Monitoring Committees (DMCs), are a complex issue. They are described in two similar documents, one from the FDA from 2006 and the other from the EMA. Another interesting document on these committees has been put out by the UK National Health Service. This posting and the…

  • Quality (QA QC QMS) Deficiencies

    Quality (QA QC QMS) Deficiencies

    In May of this year I did a posting on the Quality Management Systems (QMS) that are obligatory for DS/PV departments based on FDA’s Quality Manual and the EMA’s Good PV Guidelines Module 1. Since then I have done many audits of drug safety and PV groups around the US and Europe and, sad to…